|Description||Recombinant protein from the full-length sequence of homo sapiens Wilms tumor 1 (WT1), transcript variant A (NM_000378), with a His tag.|
|RefSeq Link||NM_000378; NP_000369; UniProt#: P19544; GeneID: 7490;|
|Synonyms||AWT1; EWS-WT1; GUD; NPHS4; WAGR; WIT-2; WT33|
|Molecular Weight||54.1 kDa|
|Purity||>90% by SDS-PAGE gel and Coomassie Blue staining|
|Applications||Antigens, Western, ELISA and other in vitro binding or in vivo functional assays, and protein-protein interaction studies; For research & development use only!|
|Formulation||Purified protein formulated in a sterile solution of PBS buffer, pH7.2, without any preservatives|
|Endotoxin||>Endotoxin level is < 0.1 ng/µg of protein (<1EU/µg)|
|Background||This gene encodes a transcription factor that contains four zinc-finger motifs at the C-terminus and a proline/glutamine-rich DNA-binding domain at the N-terminus. It has an essential role in the normal development of the urogenital system, and it is mutated in a small subset of patients with Wilms tumor. This gene exhibits complex tissue-specific and polymorphic imprinting pattern, with biallelic, and monoallelic expression from the maternal and paternal alleles in different tissues. Multiple transcript variants have been described. In several variants, there is evidence for the use of a non-AUG (CUG) translation initiation codon upstream of, and in-frame with the first AUG. Authors of PMID:7926762 also provide evidence that WT1 mRNA undergoes RNA editing in human and rat, and that this process is tissue-restricted and developmentally regulated. [provided by RefSeq, Mar 2015].|
Customers who come to this page are also interested in the following products:
There's no citations at this moment.
There's no FAQs at this moment.
There's no reviews at this moment.